1 |
Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity |
|
|
| Ji Hye Jang, Yong Koo Kang, Han Sang Park, Kiyoung Kim, Sung Soo Kim, Jae Yong Han, Hyun Wong Kim, Jong Wook Bang, Jae Shin Song, Sang Jun Park, Se Joon Woo, Kwang Sic Joo, Woong-Sun Yoo, Inyoung Chung, Yong-Wun Cho, Jong Hyun Lee, Hun Jin Choi, Yoo-Ri Chung |
|
| BMJ Open Ophthalmology. 2023; 8(1): e001166 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries |
|
|
| Mangat Ram Dogra, Anand Vinekar |
|
| Pediatric Health, Medicine and Therapeutics. 2023; Volume 14: 59 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Latest Trends in Retinopathy of Prematurity: Research on Risk Factors, Diagnostic Methods and Therapies |
|
|
| Laura Bujoreanu Bezman, Carmen Tiutiuca, Geanina Totolici, Nicoleta Carneciu, Florin Ciprian Bujoreanu, Diana Andreea Ciortea, Elena Niculet, Ana Fulga, Anamaria Madalina Alexandru, Daniela Jicman Stan, Aurel Nechita |
|
| International Journal of General Medicine. 2023; Volume 16: 937 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Research Progress on Anti-VEGF Drug Ther-apy for Retinopathy of Prematurity |
|
|
| ? ? |
|
| Advances in Clinical Medicine. 2023; 13(05): 7128 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
New trends in intravitreal anti-VEGF therapy for ROP |
|
|
| Alfredo Beccasio, Costanza Mignini, Anna Caricato, Barbara Iaccheri, Giuseppe Di Cara, Alberto Verrotti, Carlo Cagini |
|
| European Journal of Ophthalmology. 2022; : 1120672121 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis |
|
|
| Nada O. Taher, Abdullah A. Ghaddaf, Sarah A. Al-Ghamdi, Jumanah J. Homsi, Bandar J. Al-Harbi, Lugean K. Alomari, Hashem S. Almarzouki |
|
| Frontiers in Medicine. 2022; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Comparison of clinical outcomes of intravitreal bevacizumab and aflibercept in Type 1 prethreshold retinopathy of prematurity in posterior Zone II |
|
|
| AmirEftekhari Milani, Masood Bagheri, MohamadReza Niyousha, Leila Rezaei, Somayyeh Hazeri, Samad Safarpoor, Maryam Abdollahi |
|
| Journal of Current Ophthalmology. 2022; 34(1): 87 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity—a current review |
|
|
| Shing Chuen Chow, Pun Yuet Lam, Wai Ching Lam, Nicholas Siu Kay Fung |
|
| Eye. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Molecular mechanism of VEGF and its role in pathological angiogenesis |
|
|
| Ajmal Ahmad, Mohd Imtiaz Nawaz |
|
| Journal of Cellular Biochemistry. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Low-dose ranibizumab administration in retinopathy of prematurity |
|
|
| Levent Tök, Lütfi Seyrek, Özlem Yalçin Tök |
|
| International Ophthalmology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Comparison of bevacizumab, ranibizumab and aflibercept in retinopathy of prematurity treatment |
|
|
| Elçin Süren, Dilek Özkaya, Ersan Çetinkaya, Mustafa Kalayci, Kenan Yigit, Mehmet Fatih Kücük, Muhammet Kazim Erol |
|
| International Ophthalmology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Comparison of two different doses of intravitreal aflibercept in the treatment of retinopathy of prematurity |
|
|
| Dilbade Yildiz Ekinci, Asli Deger Vural |
|
| Journal of American Association for Pediatric Ophthalmology and Strabismus. 2021; 25(2): 93.e1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity |
|
|
| Hamid Riazi-esfahani, Alireza Mahmoudi, Mehdi Sanatkar, Afsar Dastjani Farahani, Fatemeh Bazvand |
|
| International Journal of Retina and Vitreous. 2021; 7(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Aflibercept for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis |
|
|
| Po-Yu (Jay) Chen, Elizabeth J. Rossin, Demetrios G. Vavvas |
|
| Ophthalmic Surgery, Lasers and Imaging Retina. 2021; 52(12): 673 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Update on the Use of Anti-VEGF Drugs in the Treatment of Retinopathy of Prematurity |
|
|
| Christopher W. Seery, Saul Betesh, Suqin Guo, Marco A. Zarbin, Neelakshi Bhagat, Rudolph S. Wagner |
|
| Journal of Pediatric Ophthalmology & Strabismus. 2020; 57(6): 351 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity |
|
|
| Ana Bety Enríquez, Robert L. Avery, Caroline R. Baumal |
|
| Asia-Pacific Journal of Ophthalmology. 2020; 9(4): 358 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
Efficacy of Aflibercept Treatment and its Effect on the Retinal Perfusion in the Oxygen-Induced Retinopathy Mouse Model of Retinopathy of Prematurity |
|
|
| Sarina Amin, Andres Gonzalez, Jade Guevara, Charlotte Bolch, Lorick Andersen, Wesley Clay Smith, SWATI AGARWAL-SINHA |
|
| Ophthalmic Research. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|